ADVANCED CANCERS
Clinical trials for ADVANCED CANCERS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CANCERS trials appear
Sign up with your email to follow new studies for ADVANCED CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug TQB2922 enters first human safety trial
Disease control Recruiting nowThis early-stage study tests a new drug called TQB2922, given as a shot under the skin, in 42 adults with advanced cancers (specifically a type of lung cancer). The main goal is to check if the drug is safe and how the body processes it. Participants must have tried standard trea…
Matched conditions: ADVANCED CANCERS
Phase: PHASE1 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Magic mushroom therapy targets cancer pain that opioids Can't touch
Symptom relief Recruiting nowThis study tests whether psilocybin (the active ingredient in magic mushrooms) can help people with advanced cancer who have pain that opioids don't relieve. Fifteen adults with advanced cancer and severe pain will receive psilocybin alongside therapy sessions. The goal is to see…
Matched conditions: ADVANCED CANCERS
Phase: PHASE2 • Sponsor: Yvan Beaussant, MD, MSci • Aim: Symptom relief
Last updated Jun 15, 2026 19:06 UTC
-
DNA decoder: 5,000 cancer patients get personalized drug matches
Knowledge-focused Recruiting nowThis study uses full genome sequencing to analyze the DNA of each participant's cancer. The goal is to find the specific genetic changes driving the cancer and match them with targeted drugs. Researchers will track how often this genetic information changes treatment decisions an…
Matched conditions: ADVANCED CANCERS
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:05 UTC